The primary response gene egr-1 encodes a sequence-specific transcription factor whose expression is necessary for antigen receptor-stimulated activation of B lymphocytes. The molecular processes involved in linking egr-1 induction to antigen receptor signaling have not been defined. The present study demonstrates that expression of an activated form of p21 =~ results in egr.1 induction similar to that previously shown after antigen receptor cross-linking. In addition, both antigen receptor cross-linking and p21 =~ use the same element in the egr-1 promoter to exert their effects. Using dominant-negative mutants of p21 =' and raf-1, we demonstrate that induction of egr-1 after antigen receptor cross-linking is mediated by activation of the p21=~/mitogenactivated protein kinase signaling pathway. While regulation of the p21 =* pathway during B cell activation has been intensively studied, this report represents the first description of a biologically relevant event associated with its activation.
.
•tivation and differentiation of B lymphocytes is initiated by an interaction between a multivalent antigen and the antigen receptor (BCR) on the cell surface. As the activation signal enters the cytoplasm, a variety of biochemical changes can be detected. These changes include phosphotidylinositol hydrolysis with subsequent Ca 2+ mobilization and protein kinase C (PKC) activation, and increased tyrosine kinase activity (for review see reference 1). In addition, the low molecular weight G protein p21 ~a~ is activated after antigen receptor cross-linking on B cells (2) (3) (4) . These studies were prompted by an early report that found that p21 r~s colocalized with the antigen receptor after crosslinking and aggregation (5) .
The p2V ~s signaling pathway has been characterized in a variety of cell types. As a G protein, p21TM is active only in the GTP-bound state (6) . Two mechanisms for regulating the activation state of p21 =~ have been described. Guanine nucleotide exchange factors (GEFs) augment the exchange of GDP for GTP and are positive activators, while GTPase activating proteins (GAPs) result in inactivation of p21 ~ (6) . Directly downstream of p21 =' in this signaling pathway is the activation of the serine/threonine kinase raf-1 (7) . The mechanism by which p21 r~ activates raf-1 is not entirely understood, but recent reports suggest that it results from recruitment of raf-1 to the cell membrane (8, 9) . Activated raf-1 phosphorylates members of the MAPK/EtLK kinase (MEK) family of dual specificity kinases (10) . After phosphorylation, MEKs activate the mitogen activated protein kinases (MAPKs) by threonine and tyrosine phosphorylation (11) . MAPK has been directly linked to the control of transcription due to 417 phosphorylation of certain transcription factors, including c-JUN (12) and a group of ETS family members collectively known as p62TCF (13) . While the linearity of the p21r"/ raf-1/MEK/MAPK pathway has been confirmed in many receptor systems, points of divergence have also been described (14) .
In B lymphocytes, activation of the p21 =~ pathway after BCR cross-linking has been extensively studied (1) . The GEF vav is activated (15, 16) and the GAP factors p120 (3, 17) and neurofibromin (18) inactivated after BCR cross-linking. In addition, recent studies (18a) have shown recruitment of the GEF SOS-1 to the BCR following receptor cross-linking. Activation offal-l, MEK, and MAPK by BCR cross-linking have all been demonstrated (2) . As yet, however, no downstream effectors of the p21~/MAPK pathway have been described in B lymphocytes. This is in contrast to T lymphocytes, where induction of the Ib2 gene, an event critical for antigen receptor-initiated proliferation, appears to be mediated by activation of the p21="/MAPK pathway (19, 20) .
Among the earliest genetic events detected after BCR crosslinking is induction of the primary response gene egr-1 (1) . Antisense studies have demonstrated that induction of egr-1 is necessary for antigen receptor-mediated activation of both B and T lyrnphocytes (21, 22) . This is presumably accomplished by induction of a second wave of function-related genes whose regulation is controlled by the transcription factor en- Plasmid Construction. The reporter plasmid pBL395 contains egr-1 promoter sequences from -395 to +65 linked to the gene encoding chloramphenicol acetyltransferase (CAT). The plasmid containing point mutations in SRE #4 was generated by the PCR method with Vent (Exo-) polymerase (New England Biolabs, Beverly, MA). The expression vector pEJ encodes a constitutively active form of cHa-ras (25) and was provided by Dr. R. Muschel (University of Pennsylvania, Philadelphia, PA). The expression vector pASN17 encodes a dominant-negative form of p21 ~'' (26) and was provided by Dr. G. Cooper (Harvard University, Cambridge, MA). The expression vector pmt-NArafencodes a dominant-negative form of raf-1 (27) and was provided by Dr. D. Schaap (The Netherlands Cancer Institute, Amsterdam, The Netherlands). Plasmid DNA was isolated by the anion-exchange method (QIAGEN). DNA from multiple preparations was used in these studies, and results were uniformly consistent.
Transient Transfection ofB Lymphocytes. B cell blasts were transiently transfected essentially as described (28, 28a) . Briefly, cells were washed once in transfection buffer (25 mM Tris-C1 [pH 7.4], 137 mM NaC1, 5 mM KCI, 0.6 mM Na2HPO4, 0.7 mM CaC12, 0.5 mM MgClz) prewarmed to 37~ and suspended in a sterile solution containing DEAE-dextran (Pharmacia Fine Chemicals, Piscataway, NJ) at 500/~g/ml in STBS and the indicated amounts of phsmid DNA. Generally, 5 x 107 cells were transfected in 5 ml of this solution for 30 min at 37~ Cells were then washed once with STBS and suspended at 106/ml in B cell assay media (without LPS). Stimuli were added 24 h after transfection for PMA (Sigma Chemical Co.) (10 ng/ml), or 40 h after transfection for BCR crosslinking. BCR cross-linking was accomplished by the addition of goat anti-/~ heavy chain (Jackson lmmunoResearch Laboratories, Inc., West Grove, PA) antibodies at 20/~g/ml.
CATAssay. To assay transfected B cell blasts for CAT activity, cells were collected 48 h after transfection by centrifugation. After lysis, CAT activity was assessed as described previously (28, 28a) . Results were quantitated on a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA). CAT activity is presented as either percent conversion or fold induction. Fold induction is defined by the ratio of the percentage of chloramphenicol converted to acetylated forms in stimulated versus unstimulated cells.
Results

Expression of a Constitutively Active Form of p21 `~' Activates the egr-1 Promoter in B Lymphocytes. Previous studies have
demonstrated that promoter elements including an SRE and two adjacent ETS motifs mediate egr-1 induction in response to BCR cross-linking (McMahon, S.B., and J.G. Monroe, manuscript submitted for publication). Because of recent studies demonstrating that activation of the p21~s/MAPK pathway is responsible for SRE-dependent expression of c-fis in fibroblasts (13) , the participation of this pathway in induction ofegr-1 in B lymphocytes was evaluated. B cell blasts were transiently transfected with a combination of a construct (pBL395) containing the egr-1 promoter upstream of the CAT reporter gene and the p21 ~' expression vector pEJ (25) . pBL395 contains egr-1 promoter sequences from -395 to + 65 which includes four SKEs, a cAMP response element, and a binding site for the EGR-1 protein, as well as potential binding sites for other transcription factors (23) . The pEJ vector encodes a p21 ~' molecule, which is constitutively active due to a substitution at amino acid 12 (glycine "~ valine), resulting in decreased GTP hydrolysis and accumulation of p21 r~ molecules in the active, GTP-bound form (25) . As is evident in Fig. 1 The wild-type or mutated versions ofpBL395 were cotransfected into B cell blasts with the p21 r~ expression vector pEJ. As shown in Fig. 2 , expression of activated p21 r~s strongly induced CAT activity from the wild-type egr-1 promoter (3.94% conversion). Mutation of SRE #4 resulted in a marked decrease in CAT activity (0.15% conversion). These values reflect a decrease from 131-fold induction with the wildtype promoter to 5-fold with the mutant SRE promoter (relative to levels obtained with the empty cassette pBR322),
indicating that SKE #4 is necessary for the induction ofegr-1 promoter activity by p21 r~S.
Expression of a Dominant-negative Mutant of p21 ~ Inhibits BCR-mediated Induction of egr-I in B Lyrnphocytes.
The demonstration that egr-1 promoter activity is induced by a constitutively active form of p21 r~S fails to directly address the role of the endogenous p21 ~ molecule in mediating egr-1 induction during BCK-mediated activation of B lymphocytes. To determine whether activation of p21 ~ plays a role in this process during normal BCR signaling, a construct encoding a dominant-negative mutant of p21 ~ (pASN17) was transfected into B lymphocytes (26) . The dominant-negative p2P* mutant contains a substitution at position 17 (serine -" asparagine) (26) . Position 17 is adjacent to the nucleotide binding pocket and, by analogy to other G proteins (26) , may be critical for interacting with the ~, phosphate of GTP. ASN17 is consequently 40-fold less efficient at binding GTP in vitro (26) and presumably inhibits the function of normal p21 r~ molecules by sequestering the cellular pool of GEF into inactive complexes (6) . Cotransfection studies were performed with pASN17 (or the empty vector, pMSG) together with the egr-1 promoter construct pBL395. As demonstrated in Fig. 3 A, was also inhibited by the expression of ASN17 (Fig. 3 B) . Like the inhibition of antigen receptor-mediated induction, this effect was evident at two different ratios of the dominantnegative/reporter vectors. Inhibition of PMA-mediated egr-1 induction by ASN17 suggests that at least some of the effects of PMA in B cells occur upstream of p21 r~s activation.
Expression of a Dominant.negative Mutant of raf-1 Inhibits
Antigen Receptor-mediated Induction of egr-1. Activation of p21 ~ by growth-promoting agents in all cell types that have been examined results in activation of MAPK. As discussed above, a key intermediate in this cascade is the serine/threonine kinase raf-1 (10). To determine whether p21 ~s activation after antigen receptor cross-linking was functioning through this pathway, a dominant-negative version of raf-1 (NAraf) was used (27) . NAtal contains only the NH2-terminal regulatory region of tar-l, lacks the COOH-terminal kinase domain, and efficiently blocks raf-l-mediated events (27) . When an expression vector (pmt-NAraf) encoding the dominant-negative raf-1 mutant was cotransfected into B cells along with pBL395, induction ofegr-1 promoter activity was substantially decreased (Fig. 4) . As with the p21 r~ dominant-negative vector, this decrease was evident whether the (1) pMSG (10) pASN-17 (10) antl-~ 
Discussion
The results presented here demonstrate that activation of the p21 r~s pathway couples antigen receptor cross-linking to induction of egr-1 in B lymphocytes. Transfection of a constitutively active form of p21 ~ resulted in a dose-dependent increase in egr-1 promoter activity. Previous studies (McMahon, S. B., and J. G. Monroe, manuscript submitted for publication) demonstrated that induction of egr-1 after antigen receptor cross-linking requires the presence of a specific SRE, that is, SRE #4. In this study, we demonstrate that SRE #4 is also necessary for egr-1 induction in response to activated p21 ~. Finally, using dominant-negative mutants of p21TM and tar-l, we demonstrate that induction of egr-1 promoter activity after BCR cross-linking involves activation of the p21raVraf-1/MAPK pathway. By using transient transfection of primary B cells, we have been able to directly implicate this pathway in activation of the egr-1 promoter.
In addition to stimulation ofB lymphocytes by antigen receptor cross-linking, we examined the effects of PMA treatment. PMA treatment directly activates PKC. As such, the finding that the dominant-negative p21 ~ mutant inhibited the PMA effect was somewhat unexpected and suggests that the effect of PMA on egr-1 transcription is mediated through the p21 "~ pathway. When these studies were initiated, PKC activation had not been shown to effect any of the early events in the p21 TM pathway. Recent reports have suggested a mechanism for the inhibition seen in Fig. 3 by demonstrating that in addition to activating PKC, PMA can directly bind and activate the GEF vav (30) . This potential effect of PMA on an early regulatory component in the p21 ~' pathway may explain the results obtained here, which show that inhibitory mutants of p21TM and raf-1 block induction of egr-1 by PMA.
As already noted, in B lymphocytes, egr-1 induction after BCK cross-linking or by expression of an activation form of p21TM (shown here) requires a specific SRE (SRE #4). This is noteworthy since the egr-1 gene contains five SREs, each of which are capable of binding SKF and regulating transcription in various cell types. In myeloid cells, for example, a variety of stimuli, including PMA, preferentially require SRE #5 for induction (31) , while in PC12 cells, SREs #1 and #2 are necessary for nerve growth factor-induced expression (32) . Similar to the studies presented here, expression of the v-tar oncogene in fibroblasts induces egr-1 promoter activity with a preference for SRE #4 (33) . These results suggest a requirement for SRE #4 by receptors and stimuli that activate the p21TM signaling pathway. A potential explanation for preferential utilization of SRE #4 by stimuli that activate the p21 "s pathway may be provided by recent studies. Induction of c-fis by growth factors in fibroblasts results from phosphorylation of p62TCF by MAPK (13) . Furthermore, p62TCF binds to a subset of ETS motifs that are adjacent to SREs (13) . In the egr-1 promoter, motifs that are adjacent to SREs (13) . In the egr-1 promoter, high affinity p62TCF binding sites occur at only three locations, two of which are adjacent to SRE #4 (13, 23) . We have recently shown that the two p62TCF binding motifs adjacent to SRE #4 are necessary for egr-1 promoter activity in response to BCR cross-linking or PMA treatment (McMahon, S. B., and J. G. Monroe, manuscript submitted for publication). Therefore, the presence of these motifs adjacent to SRE #4 is likely to mediate its preferential utilization in response to antigen receptor activation of the p21TM pathway in B lymphocytes by allowing efficient ternary complex formation by p62TCF and SRF. Involvement of the p21 r~' pathway in BCR-generated signal transduction in B lymphocytes has been the subject of intensive study. Consequently, a significant amount of information is available regarding the proteins that regulate p21 r~S in B cells (4, 5, (15) (16) (17) . In addition, several studies have identified the kinases that are active in this pathway (1, 2) . However, to date, no functional consequence of p21 ~S activation in B cells has been demonstrated. In this report, we show that induction ofegr-1, a gene whose expression is necessary for lymphocyte activation, is mediated by the p21 r~s pathway after cross-linking of the B cell antigen receptor. These findings assign a crucial role to p21 TM in B cell activation.
